When a parent develops dementia, it is natural for their children to wonder whether they might face the same diagnosis. Does dementia run in families? And if a close relative has Alzheimer’s disease, how much does that increase your own risk?
The answer is more complex than inheritance alone. Most dementia is not caused by a single inherited genetic mutation. Instead, it usually develops through a combination of ageing, genetic susceptibility, vascular and metabolic health, lifestyle, environmental influences and changes in how genes are regulated over a person’s lifetime.
Understanding these interacting factors can help put family history into perspective and identify the relatively small number of families who may benefit from specialist genetic assessment.

Dementia is an umbrella term for conditions that affect memory, thinking, communication and everyday functioning. Alzheimer’s disease is the most common cause, but other forms include vascular dementia, dementia with Lewy bodies and frontotemporal dementia (FTD).
Although some forms have a stronger genetic component than others, having a parent or grandparent with dementia does not mean you will necessarily develop it.
For most people, dementia arises through a combination of factors, including:
It is also increasingly recognised that dementia, particularly in older people, may involve more than one underlying pathology. Alzheimer’s-related amyloid and tau changes can coexist with vascular injury, Lewy body pathology and other neurodegenerative processes.
This means that dementia risk cannot usually be explained by a single gene or biological mechanism.
Two types of genetic influence are important to understand.
Risk genes: influencing susceptibility
Risk genes increase the likelihood of developing a condition but do not determine whether it will occur.
One of the best-known examples is the APOE gene, which has several variants, including APOE ε2, APOE ε3 and APOE ε4. Everyone inherits two copies, one from each parent.
APOE ε4 is associated with an increased risk of Alzheimer’s disease, particularly when a person inherits two copies. However, carrying one or even two copies does not make Alzheimer’s inevitable. Equally, people without APOE ε4 can develop the disease.
Genetic susceptibility therefore represents one part of a much broader picture involving ageing, health, lifestyle and biological processes.
In a small proportion of families, dementia is caused by a mutation in a single gene. These are often described as familial or autosomal dominant forms.
In familial Alzheimer’s disease, mutations in APP, PSEN1 and PSEN2 can directly cause the condition. Certain mutations in MAPT, GRN and C9orf72 are associated with familial frontotemporal dementia.
These conditions are rare and often develop at a younger age, sometimes in a person’s 30s, 40s or 50s.
Where a parent carries a confirmed autosomal dominant disease-causing mutation, each child has a 50% chance of inheriting it. Specialist genetic counselling is important before testing.
The vast majority of Alzheimer’s cases are not directly inherited through a single faulty gene.
Late-onset Alzheimer’s, which generally develops after the age of 65, reflects the interaction of genetic susceptibility, ageing and multiple health and environmental factors.
Having a parent or sibling with Alzheimer’s may increase your own risk, particularly if several close relatives have been affected. However, family history does not mean that you will develop the condition.
Early-onset dementia, diagnosed before the age of 65, deserves particular attention. Although some cases are caused by inherited mutations, many are not. A younger age at onset alone does not establish a genetic cause.

An important development in dementia research is the growing recognition that cognitive decline frequently reflects several interacting biological processes.
For example, a person may have Alzheimer’s-related amyloid and tau pathology alongside small-vessel disease, previous vascular injury or other neurodegenerative changes.
Epigenetic mechanisms may also influence how genes are expressed without changing the underlying DNA sequence. These mechanisms can be affected by ageing, environmental exposures, metabolic health and other biological influences.
Consequently, two people with similar genetic backgrounds may experience very different cognitive outcomes.
This reinforces the importance of looking beyond family history and considering the individual’s overall brain health.
The likelihood of a genetic contribution varies between dementia types.
Frontotemporal dementia (FTD) has a stronger familial association than many other common forms. Mutations in MAPT, GRN and C9orf72 account for a proportion of inherited cases.
Vascular dementia is not usually inherited directly, although risk factors such as hypertension, diabetes and cardiovascular disease can run in families. Dementia with Lewy bodies can involve genetic susceptibility, but a single inherited mutation does not usually explain most cases.
Rare inherited conditions, including Huntington’s disease and certain familial prion diseases, can also cause dementia as part of their clinical presentation.
A pattern of several relatives developing dementia, particularly at a younger age, may justify specialist genetic assessment.
For most people, genetic testing is not routinely recommended simply because a parent or grandparent developed dementia. Testing may be appropriate when several relatives have developed dementia at a relatively young age or when a specific inherited condition is suspected.
Testing for a disease-causing mutation is different from testing for susceptibility variants such as APOE ε4. An APOE result cannot establish whether someone will develop Alzheimer’s disease.
Genetic testing is a significant personal decision and should be accompanied by specialist advice and genetic counselling.
Although genetic inheritance cannot be changed, many factors associated with brain health can be addressed.
The 2024 Lancet Commission identified 14 potentially modifiable risk factors and estimated that around 45% of dementia cases worldwide could potentially be prevented or delayed by addressing these factors across the life course.
They include high blood pressure, high LDL cholesterol, diabetes, hearing loss, untreated vision loss, smoking, physical inactivity, obesity, depression, social isolation and excessive alcohol consumption.
Practical steps include:
These measures do not guarantee prevention, but they can help reduce exposure to recognised risk factors, including for people with a family history of dementia.
A family history of dementia is not, in itself, a reason to assume that you will develop the condition. However, persistent changes in memory, thinking or behaviour should be investigated.
Possible warning signs include:
These symptoms do not automatically indicate dementia. Sleep disorders, depression, stress, thyroid problems, vitamin deficiencies and certain medications can also affect memory and concentration.
At the Memory & Brain Health Centre at Mubadala Health Dubai, patients can undergo specialist assessment led by Dr Derk W Krieger, Consultant Neurologist.
Assessment considers symptoms, medical history and the impact of cognitive changes on everyday life. It may include cognitive testing, neurological examination, blood tests and brain imaging such as MRI. Where appropriate, Alzheimer’s disease biomarkers, including amyloid and phosphorylated tau (p-tau), may support the diagnostic investigation.
Through its partnership with M42’s National Reference Laboratory (NRL), the centre can also support access to advanced diagnostic testing.

Dementia diagnosis and treatment are evolving rapidly. Advances in blood-based biomarkers are helping clinicians identify biological changes associated with Alzheimer’s disease more accurately and earlier in the diagnostic process.
Disease-modifying treatments are also becoming available for eligible patients with early Alzheimer’s disease. These treatments target aspects of the underlying disease process and can slow clinical progression in appropriately selected patients, although they do not cure the condition.
These developments make early specialist assessment increasingly important. An accurate diagnosis can help determine whether new diagnostic or treatment options are appropriate.
The Brain Health Centre at Mubadala Health Dubai brings together M42’s clinical and diagnostic capabilities with the specialist expertise of Re:Cognition Health, a UK-based provider with more than 15 years of experience in cognitive and neurological care.
Through this collaboration, patients have access to an integrated approach to brain and memory health, combining specialist neurological assessment, advanced diagnostic imaging, biomarker testing and evidence-based treatment pathways.
Re:Cognition Health’s multidisciplinary expertise spans neurology, neuroradiology, neuropsychology and psychiatry, supporting the assessment and management of Alzheimer’s disease, cognitive impairment and other neurodegenerative conditions.
The collaboration aims to support earlier diagnosis, informed treatment decisions and ongoing care for patients and their families.
Understanding your family history can provide useful information, but it should not define your expectations for the future.
Most dementia is not directly inherited through a single gene. Ageing, genetic susceptibility, vascular and metabolic health, lifestyle and other biological processes all contribute to an individual’s risk.
If you are concerned about changes in memory, thinking or behaviour, the Memory & Brain Health Centre at Mubadala Health Dubai can provide specialist assessment and guidance.
To arrange an appointment, call 800 77.
This article is intended for general information and does not replace professional medical advice, diagnosis or treatment. Always consult a qualified healthcare professional about concerns relating to memory, cognition or dementia. In a medical emergency in the UAE, call 998 or attend your nearest emergency department.
This article is for general information only and does not replace professional medical advice, diagnosis or treatment. Always consult a qualified healthcare professional about your individual situation. If you have a medical emergency, call 998 or go to your nearest emergency department.
Author: Dr. Derk Wolfgang Krieger - Mubadala Health Dubai, UAE
In families with a fully penetrant autosomal dominant mutation, the mutation itself does not skip generations, although a carrier may not always develop symptoms if the mutation has incomplete penetrance. More commonly, family patterns reflect shared genetic susceptibility and environmental or health factors.
A grandparent who developed Alzheimer’s later in life may modestly increase your risk. However, this does not mean you will develop the condition. Several close relatives affected at a younger age are more significant and may warrant specialist assessment.
No. Although inherited mutations cause some cases, many cases of early-onset dementia have no identified single-gene cause.
Symptoms can include increasing forgetfulness, difficulty finding words, problems with planning and decision-making, changes in behaviour and difficulty managing familiar activities. Persistent changes should be assessed by a medical professional.